Discover the secret to rapid tech transfer and expedited batch release in aseptic fill/finish with real case studies from a global CDMO. And that’s not all — watch the audience Q&A to uncover the insights that your industry peers were most eager to gain.
From optimized tech transfer, to expedited batch release, to a team culture of expertise, David King, Director of Drug Product Operations at Samsung Biologics, will discuss pivotal moments in past projects and how Samsung Biologics leverages its CDMO expertise to meet accelerated timelines in aseptic fill/finish manufacturing.
In this webinar, you will learn:
- How Samsung Biologics integrates their clients' operation philosophies with their aseptic fill/finish expertise, equipment design, and facility
- How to build client/CDMO relationships based on trust and expertise
- Preemptive approaches to ensure a rapid and seamless tech transfer for on-time delivery to patients
- Personalized insights from the audience Q&A at the end of the presentation
